Influence of prior influenza vaccination on antibody and B-cell responses. - sprookjes - yvandenbroek - TriplyDB

Influence of prior influenza vaccination on antibody and B-cell responses.

Influence of prior influenza vaccination on antibody and B-cell responses.

http://www.wikidata.org/entity/Q33361605

about

Utilizing population variation, vaccination, and systems biology to study human immunology Immunogenicity and efficacy of flagellin-fused vaccine candidates targeting 2009 pandemic H1N1 influenza in mice Low seroprevalent species D adenovirus vectors as influenza vaccines.Immunologic consequences of chemotherapy for ovarian cancer: impaired responses to the influenza vaccine Antibody response to influenza A(H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine: effect of prior monovalent inactivated vaccine.Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals.Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms.Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.Seroprotective antibodies to 2011 variant influenza A(H3N2v) and seasonal influenza A(H3N2) among three age groups of US Department of Defense service members.Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine.ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination.Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans.Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies.Elicitation of anti-1918 influenza virus immunity early in life prevents morbidity and lower levels of lung infection by 2009 pandemic H1N1 influenza virus in aged mice.Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender.Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine.Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.Humoral antibody response after receipt of inactivated seasonal influenza vaccinations one year apart in children.Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.Polysaccharide-specific B cell responses to vaccination in humans Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition.The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals.Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccine Global analyses of human immune variation reveal baseline predictors of postvaccination responses.CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization.TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors.Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy.The effect of age and recent influenza vaccination history on the immunogenicity and efficacy of 2009-10 seasonal trivalent inactivated influenza vaccination in children Characterization of influenza vaccine immunogenicity using influenza antigen microarrays.Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial.Genetic measurement of memory B-cell recall using antibody repertoire sequencing.Variation in the human immune system is largely driven by non-heritable influences

P2860

Q26799374-A579BA8F-B55B-481E-8623-75B4BA0D1E23 Q28743887-92F09492-18B8-4B06-A0F1-1FC84B58A826 Q30353263-A7983017-D2D1-4785-A717-5D0C51E66905 Q30353632-CF4A778D-181C-48BE-8CC3-340659CB3947 Q30357144-898B3EE9-F68B-42F3-AFAD-D12350FFBCDB Q30360439-0BA74099-647A-4379-B738-7E2630B79DE5 Q30360610-EF01DB1D-3347-42A0-94A1-E1316FBC16A3 Q30362811-DB6A4578-0D24-4737-9C31-75B8CA68BF74 Q30364187-13F806F4-F4F6-4FCF-B79C-3135C6BB338B Q30368005-65CED5F3-2313-47E6-A6A4-42F3CACDFD8A Q30373137-950BC22F-9B50-434E-B04B-960A16A00970 Q30376724-9CE60597-361F-492D-A236-FE9F87B52461 Q30382809-2555ECDD-46C3-4E43-9D1C-29B017E3F1BB Q30384943-3CFB61F9-9B58-4E5A-9DDE-D5F9C0C4F075 Q30388557-292A16CC-68B8-424C-AD2F-DB1B407828BE Q30390811-798E38C0-7C45-4519-A720-6F819DF5913C Q30403507-017B8C98-7F12-4660-B573-FAA981284015 Q30405145-C8611034-6D5F-4A04-96B8-B36CE49C6010 Q30410129-24DA3432-95E2-4FB6-8FC3-D1DB2E48126D Q30411189-0B6905FC-56AB-4D88-B5FF-BBD6C466698A Q30412266-6CA8F8AC-7B81-4463-A414-A664560C937B Q30414665-3F4F6E6E-9FC6-4DD7-BD4D-E7E750A20CAE Q30417799-0FA5EC55-BFD3-4822-9924-EA91E1E13A65 Q33554684-69558444-E93A-4983-8F20-D4869EE6B54E Q33577958-DF5CDC30-5080-4BA2-AD0C-08397A91B6AE Q33762211-64986200-3065-431E-B138-CE7F827FE57B Q34021580-CC64201F-80B4-4D1E-A08F-5699A71B4C0D Q34032367-69CC085F-6A3B-4525-A011-CD97B5829C15 Q34070648-A519290C-36AB-4B17-AF1F-0DB4CD103CF9 Q34104346-124D8530-8BAC-4005-9E76-A4D06D82E120 Q34205800-1097E12D-238C-46F6-84D4-ED613BC16DE4 Q34216832-C3A5AFB6-19F4-4E52-90C4-66924A05586B Q34313957-AB8F2A23-A191-4228-A31D-277C34ADC07B Q34354440-D470F925-E137-4734-8130-22AF2AAEC4C6 Q34541705-09BA3445-5DD2-47A1-BE51-E8BBED9F8A80 Q34648699-700E004F-CA00-4442-83B7-EE9127600C1C Q34755553-FD502176-37A5-4FF4-BAAE-A124C0F82129 Q34768241-4B39B223-0CEC-473E-B9C1-53490029890C Q34880392-00664585-C4D4-48FF-BC0B-596D34435548 Q34998817-3D290F29-7756-4605-A67C-804A76DADB78

P2860

Influence of prior influenza vaccination on antibody and B-cell responses.

http://www.wikidata.org/entity/Q33361605

description

2008 nî lūn-bûn

@nan

2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Influence of prior influenza vaccination on antibody and B-cell responses.

@ast

Influence of prior influenza vaccination on antibody and B-cell responses.

@en

type

label

Influence of prior influenza vaccination on antibody and B-cell responses.

@ast

Influence of prior influenza vaccination on antibody and B-cell responses.

@en

prefLabel

Influence of prior influenza vaccination on antibody and B-cell responses.

@ast

Influence of prior influenza vaccination on antibody and B-cell responses.

@en

P1433

Q33361605-E378F0B1-FD18-4615-BD0F-C581BCCC5DD7

P1476

Q33361605-4B5592B9-E28F-4F89-8676-31FBC7EF15EB

P2093

Q33361605-142D87FF-5C5B-471A-8C0C-5B1A82901BD4

Q33361605-6BE52052-2AE9-4532-9EE9-C70F968E874A

Q33361605-73DA7287-F74C-4620-993F-545D910E0AFA

Q33361605-A45391F5-0E15-4D82-A374-6B9B49475670

Q33361605-D90A028B-DE0F-4872-9680-66112E27C970

Q33361605-E7339B41-F56E-4312-A3D2-5A98033F6112

P2860

Q33361605-0EE67680-C8D4-4ADA-AE53-E352365EE770

Q33361605-1293EDB9-41F3-4339-BB31-379C4A690585

Q33361605-24CE943A-245C-4452-AF49-8D46001EE576

Q33361605-259716D9-99D5-4677-A650-18996FE82BBB

Q33361605-2AE0D1AA-E492-41C5-9545-168FCA47C904

Q33361605-2F2D09BD-FF77-40EF-A0B3-6267BC1AB7D8

Q33361605-2F5C360D-20DD-4F99-AC63-250C9009110C

Q33361605-38EFED6A-1A4E-4FB4-AD80-108EBDC8F309

Q33361605-39210C5F-C712-4DF5-B955-9B7DD1A51A6F

Q33361605-3A875DDE-74A6-4472-9FB8-45F9C4C4412F

P304

Q33361605-432BC2AF-1441-418C-8F69-E348D2A5CA41

P31

Q33361605-4ACA6398-D274-4C2C-AD69-8B6D44C42BFD

P356

Q33361605-B8237FF5-C942-4E9B-8096-D68F25128B6D

P407

Q33361605-08876234-7210-44C1-B23E-424D428678A8

P433

Q33361605-16CDA542-F1F0-4A84-A842-DAD5E4B19BE5

P478

Q33361605-14852A5E-B6F0-4BA9-9B72-53047BC92DC1

P50

Q33361605-B1DFDC33-27D5-41A4-8804-EEEF5674B2FB

P577

Q33361605-9897A9FD-F888-4FAD-9D35-063EB75A2D89

P5875

Q33361605-3ABD9D45-99B7-4F4E-BADD-C023D84B3A76

P698

Q33361605-C788CD90-CFD3-4F0F-88CE-CB4AF5834417

P921

Q33361605-6F4B5067-C706-45F0-B688-3D9799CADA42

P932

Q33361605-6927A74E-9546-4DF4-90C2-0B40F26DF633

P356

JOURNAL.PONE.0002975

P1433

P1476

Influence of prior influenza vaccination on antibody and B-cell responses.

@en

P2093

Ann M Arvin

http://www.w3.org/2001/XMLSchema#string

Cornelia L Dekker

http://www.w3.org/2001/XMLSchema#string

George W Kemble

http://www.w3.org/2001/XMLSchema#string

Sanae Sasaki

http://www.w3.org/2001/XMLSchema#string

Tyson H Holmes

http://www.w3.org/2001/XMLSchema#string

Xiao-Song He

http://www.w3.org/2001/XMLSchema#string

P2860

Influenza-associated hospitalizations in the United States

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses.

Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.

Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.

Quantifying influenza vaccine efficacy and antigenic distance.

A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults

Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.

Variable efficacy of repeated annual influenza vaccination

P304

e2975

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0002975

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Harry B. Greenberg

P577

2008-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23181585

http://www.w3.org/2001/XMLSchema#string

P698

18714352

http://www.w3.org/2001/XMLSchema#string

P921

P932

2500171

http://www.w3.org/2001/XMLSchema#string